Effect of kaempferol on the transgenic Drosophila model of Parkinson's disease

Sci Rep. 2020 Aug 14;10(1):13793. doi: 10.1038/s41598-020-70236-2.

Abstract

The present study was aimed to study the effect of kaempferol, on the transgenic Drosophila model of Parkinson's disease. Kaempferol was added in the diet at final concentration of 10, 20, 30 and 40 µM and the effect was studied on various cognitive and oxidative stress markers. The results of the study showed that kaempferol, delayed the loss of climbing ability as well as the activity of PD flies in a dose dependent manner compared to unexposed PD flies. A dose-dependent reduction in oxidative stress markers was also observed. Histopathological examination of fly brains using anti-tyrosine hydroxylase immunostaining has revealed a significant dose-dependent increase in the expression of tyrosine hydroxylase in PD flies exposed to kaempferol. Molecular docking results revealed that kaempferol binds to human alpha synuclein at specific sites that might results in the inhibition of alpha synuclein aggregation and prevents the formation of Lewy bodies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Animals, Genetically Modified
  • Disease Models, Animal*
  • Drosophila / genetics
  • Drosophila / metabolism
  • Humans
  • Kaempferols / administration & dosage
  • Kaempferols / metabolism
  • Kaempferols / pharmacology*
  • Lewy Bodies / drug effects
  • Lewy Bodies / metabolism
  • Motor Activity / drug effects
  • Parkinson Disease / genetics
  • Parkinson Disease / metabolism*
  • Parkinson Disease / physiopathology
  • Protein Aggregation, Pathological / prevention & control*
  • Tyrosine 3-Monooxygenase / metabolism*
  • alpha-Synuclein / antagonists & inhibitors*
  • alpha-Synuclein / chemistry
  • alpha-Synuclein / metabolism

Substances

  • Kaempferols
  • alpha-Synuclein
  • kaempferol
  • Tyrosine 3-Monooxygenase